CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

PKC412 100mg  | ≥99%

CSNpharm

PKC412 is a broad spectrum protein kinase inhibitor and inhibits conventional PKC isoforms (α, β, γ), PDFRβ, VEGFR2, Syk, PKCη, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR.

More Information Supplier Page

PKC412 1mg  | ≥99%

CSNpharm

PKC412 is a broad spectrum protein kinase inhibitor and inhibits conventional PKC isoforms (α, β, γ), PDFRβ, VEGFR2, Syk, PKCη, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR.

More Information Supplier Page

PKC412 10mg  | ≥99%

CSNpharm

PKC412 is a broad spectrum protein kinase inhibitor and inhibits conventional PKC isoforms (α, β, γ), PDFRβ, VEGFR2, Syk, PKCη, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR.

More Information Supplier Page

PKC412 5mg  | ≥99%

CSNpharm

PKC412 is a broad spectrum protein kinase inhibitor and inhibits conventional PKC isoforms (α, β, γ), PDFRβ, VEGFR2, Syk, PKCη, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR.

More Information Supplier Page

PKCβ Inhibitor 1mg  | ≥98%

CSNpharm

PKCβ Inhibitor is a potent, reversible and ATP-competitive PKCβ inhibitor with IC50 values of 5nM and 21nM for PKCβII and βI, respectively.

More Information Supplier Page

PKCβ Inhibitor 5mg  | ≥98%

CSNpharm

PKCβ Inhibitor is a potent, reversible and ATP-competitive PKCβ inhibitor with IC50 values of 5nM and 21nM for PKCβII and βI, respectively.

More Information Supplier Page

PKCβ Inhibitor 10mg  | ≥98%

CSNpharm

PKCβ Inhibitor is a potent, reversible and ATP-competitive PKCβ inhibitor with IC50 values of 5nM and 21nM for PKCβII and βI, respectively.

More Information Supplier Page

PKR-IN-C16 5mg  | ≥98%

CSNpharm

PKR-IN-C16 is a specific protein kinase (PKR) inhibitor. It shows to effectively inhibit RNA-induced PKR autophosphorylation (IC50 = 210 nM) and rescue PKR-dependent translation block (IC50 = 100 nM).

More Information Supplier Page

PKR-IN-C16 1mg  | ≥98%

CSNpharm

PKR-IN-C16 is a specific protein kinase (PKR) inhibitor. It shows to effectively inhibit RNA-induced PKR autophosphorylation (IC50 = 210 nM) and rescue PKR-dependent translation block (IC50 = 100 nM).

More Information Supplier Page

PKR-IN-C16 10mg  | ≥98%

CSNpharm

PKR-IN-C16 is a specific protein kinase (PKR) inhibitor. It shows to effectively inhibit RNA-induced PKR autophosphorylation (IC50 = 210 nM) and rescue PKR-dependent translation block (IC50 = 100 nM).

More Information Supplier Page

Plantamajoside 50mg  | ≥99%

CSNpharm

Plantamajoside, a natural product isolated and purified from the herb of Plantago depressa Willd., has anti-hepatotoxic, anti-inflammatory, antinociceptive activities, improving sexual function and antioxidant activity.

More Information Supplier Page

Plantamajoside 25mg  | ≥99%

CSNpharm

Plantamajoside, a natural product isolated and purified from the herb of Plantago depressa Willd., has anti-hepatotoxic, anti-inflammatory, antinociceptive activities, improving sexual function and antioxidant activity.

More Information Supplier Page

Plantamajoside 5mg  | ≥99%

CSNpharm

Plantamajoside, a natural product isolated and purified from the herb of Plantago depressa Willd., has anti-hepatotoxic, anti-inflammatory, antinociceptive activities, improving sexual function and antioxidant activity.

More Information Supplier Page

Plantamajoside 100mg  | ≥99%

CSNpharm

Plantamajoside, a natural product isolated and purified from the herb of Plantago depressa Willd., has anti-hepatotoxic, anti-inflammatory, antinociceptive activities, improving sexual function and antioxidant activity.

More Information Supplier Page

Plantamajoside 10mg  | ≥99%

CSNpharm

Plantamajoside, a natural product isolated and purified from the herb of Plantago depressa Willd., has anti-hepatotoxic, anti-inflammatory, antinociceptive activities, improving sexual function and antioxidant activity.

More Information Supplier Page

Platycodin D 100mg  | ≥95%

CSNpharm

Platycodin D is a natural product isolated and purified from the root of Platycodon grandiflorum., which may stimulate TNF-α synthesis or inhibit degradation of TNF-α mRNA, and is an Hsp90 inhibitor which disrupting the co-chaperone interaction of Hsp90/cell division cycle protein 37 (Cdc37) and subsequently degrading multiple Hsp90 client proteins without the feedback increase of […]

More Information Supplier Page

Platycodin D 50mg  | ≥95%

CSNpharm

Platycodin D is a natural product isolated and purified from the root of Platycodon grandiflorum., which may stimulate TNF-α synthesis or inhibit degradation of TNF-α mRNA, and is an Hsp90 inhibitor which disrupting the co-chaperone interaction of Hsp90/cell division cycle protein 37 (Cdc37) and subsequently degrading multiple Hsp90 client proteins without the feedback increase of […]

More Information Supplier Page

Platycodin D 25mg  | ≥95%

CSNpharm

Platycodin D is a natural product isolated and purified from the root of Platycodon grandiflorum., which may stimulate TNF-α synthesis or inhibit degradation of TNF-α mRNA, and is an Hsp90 inhibitor which disrupting the co-chaperone interaction of Hsp90/cell division cycle protein 37 (Cdc37) and subsequently degrading multiple Hsp90 client proteins without the feedback increase of […]

More Information Supplier Page

Platycodin D 10mg  | ≥95%

CSNpharm

Platycodin D is a natural product isolated and purified from the root of Platycodon grandiflorum., which may stimulate TNF-α synthesis or inhibit degradation of TNF-α mRNA, and is an Hsp90 inhibitor which disrupting the co-chaperone interaction of Hsp90/cell division cycle protein 37 (Cdc37) and subsequently degrading multiple Hsp90 client proteins without the feedback increase of […]

More Information Supplier Page

Platyphyllenone 5mg  | ≥98%

CSNpharm

Platyphyllone, a natural product isolated and purified from the bark of Alnus japonica, shows promising anti-filarial activity, and strongly activity against influenza virus.

More Information Supplier Page

Platyphyllenone 1mg  | ≥98%

CSNpharm

Platyphyllone, a natural product isolated and purified from the bark of Alnus japonica, shows promising anti-filarial activity, and strongly activity against influenza virus.

More Information Supplier Page

Platyphyllonol 1mg  | ≥98%

CSNpharm

Platyphyllonol, a natural product isolated and purified from the stem bark of Alnus hirsuta., is moderately active against KBNP-0028 (H9N2) avian influenza virus as compared with zanamivir.

More Information Supplier Page

Platyphyllonol 5mg  | ≥98%

CSNpharm

Platyphyllonol, a natural product isolated and purified from the stem bark of Alnus hirsuta., is moderately active against KBNP-0028 (H9N2) avian influenza virus as compared with zanamivir.

More Information Supplier Page

Pleconaril 25mg  | ≥99%

CSNpharm

Pleconaril is a capsid inhibitor used previously to treat enterovirus infections. Pleconaril is effective in inhibiting replication with an IC50 of 50 nM.

More Information Supplier Page

Pleconaril 100mg  | ≥99%

CSNpharm

Pleconaril is a capsid inhibitor used previously to treat enterovirus infections. Pleconaril is effective in inhibiting replication with an IC50 of 50 nM.

More Information Supplier Page

Pleconaril 10mg  | ≥99%

CSNpharm

Pleconaril is a capsid inhibitor used previously to treat enterovirus infections. Pleconaril is effective in inhibiting replication with an IC50 of 50 nM.

More Information Supplier Page

Pleconaril 250mg  | ≥99%

CSNpharm

Pleconaril is a capsid inhibitor used previously to treat enterovirus infections. Pleconaril is effective in inhibiting replication with an IC50 of 50 nM.

More Information Supplier Page

Pleconaril 5mg  | ≥99%

CSNpharm

Pleconaril is a capsid inhibitor used previously to treat enterovirus infections. Pleconaril is effective in inhibiting replication with an IC50 of 50 nM.

More Information Supplier Page

Pleconaril 50mg  | ≥99%

CSNpharm

Pleconaril is a capsid inhibitor used previously to treat enterovirus infections. Pleconaril is effective in inhibiting replication with an IC50 of 50 nM.

More Information Supplier Page

Plerixafor 10mg  | ≥99%

CSNpharm

Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 5mg  | ≥99%

CSNpharm

Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 100mg  | ≥99%

CSNpharm

Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 50mg  | ≥99%

CSNpharm

Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 8HCl 5mg  | ≥99%

CSNpharm

Plerixafor 8HCl is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 8HCl 100mg  | ≥99%

CSNpharm

Plerixafor 8HCl is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 8HCl 10mg  | ≥99%

CSNpharm

Plerixafor 8HCl is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 8HCl 50mg  | ≥99%

CSNpharm

Plerixafor 8HCl is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plumbagin 25mg  | ≥99%

CSNpharm

Plumbagin is an anticancer agent, induces G2/M cell cycle arrest and apoptosis in A549 cells through JNK-dependent p53 Ser15 phosphorylation and inhibits A549 and MDA-MD-231 tumour xenograft growth in nude mice.

More Information Supplier Page

Plumbagin 100mg  | ≥99%

CSNpharm

Plumbagin is an anticancer agent, induces G2/M cell cycle arrest and apoptosis in A549 cells through JNK-dependent p53 Ser15 phosphorylation and inhibits A549 and MDA-MD-231 tumour xenograft growth in nude mice.

More Information Supplier Page

Plumbagin 10mg  | ≥99%

CSNpharm

Plumbagin is an anticancer agent, induces G2/M cell cycle arrest and apoptosis in A549 cells through JNK-dependent p53 Ser15 phosphorylation and inhibits A549 and MDA-MD-231 tumour xenograft growth in nude mice.

More Information Supplier Page

Plumbagin 50mg  | ≥99%

CSNpharm

Plumbagin is an anticancer agent, induces G2/M cell cycle arrest and apoptosis in A549 cells through JNK-dependent p53 Ser15 phosphorylation and inhibits A549 and MDA-MD-231 tumour xenograft growth in nude mice.

More Information Supplier Page

PluriSln 1 5mg  | ≥99%

CSNpharm

PluriSln 1 is an inhibitor of cell pluripotency and stearoyl-coA desaturase (SCD1) that can induce ER stress and apoptosis in hPSCs.

More Information Supplier Page

PluriSln 1 50mg  | ≥99%

CSNpharm

PluriSln 1 is an inhibitor of cell pluripotency and stearoyl-coA desaturase (SCD1) that can induce ER stress and apoptosis in hPSCs.

More Information Supplier Page

PluriSln 1 10mg  | ≥99%

CSNpharm

PluriSln 1 is an inhibitor of cell pluripotency and stearoyl-coA desaturase (SCD1) that can induce ER stress and apoptosis in hPSCs.

More Information Supplier Page